Bixiye
QP49-25 MHCP Pharmacy Benefit Exclusion for Imaavy™, Lutrate Depot®, Tepylute, Ustekinumab and Ustekinumab-aekn
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Natiijooyinka Raadinta
Soo bandhiga 3301 - 3310 ee natiijooyinka 4130
Bixiye
QP48-25 Commercial Pharmacy Benefit Exclusion for Imaavy™, Ustekinumab and Ustekinumab-aekn
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Bixiye
QP47-25 Updated Accessibility Requirements
Taariikhda wax ku ool ah ee barnaamijka: Jun 11, 2025
Bixiye
QP54-25 “Serious Illness Conversations: Improving Patient Care at End of Life” Training Available July/August 2025
Taariikhda wax ku ool ah ee barnaamijka: Jun 25, 2025
Bixiye
QP53-25 Update for New-to-Market Medical Drugs: nipocalimab-aahu
Taariikhda wax ku ool ah ee barnaamijka: Jun 25, 2025
Bixiye
2025 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2025